Queen Mary BioEnterprises Innovation Centre is looking for 24 volunteers to inject with coronavirus and participate in their flu camp
They will be paid about $4,588 for their troubles.
This isn’t the latest twisted Stephen King novel. Rather, it’s an attempt by medical research and development company Hvivo to create a vaccine for the deadly disease which has killed more than 3,800 across the globe.
The human guinea pigs — who will receive a battery of tests before being selected — will be given two of the virus’ weaker strains, 0C43 and 229E, which should cause mild respiratory symptoms. They will then be given new or existing vaccines.
Doctors — who will wear protective clothing and ventilators — will analyze the patients’ responses to the vaccine, and the results will help researchers focus on the most effective treatments in order to fast-track them.
Aside from the actual downside of being sick, participants must stay in quarantine for two weeks, eat a restricted diet and avoid human contact and exercise.
The East London-based company is just one of 20 firms joining the global race to find a vaccine that could be ready by next winter, reports the Times of London.
“Drugs companies can get a very good idea within a few months of starting a vaccine study whether it’s working or not, using such a small sample of people,” said Andrew Catchpole, Hvivo’s chief scientist.
The testing will begin once Hvivo gets the go-ahead from UK’s Medicines and Healthcare products Regulatory Agency.
Photo Credit: nypost.com